Related Experiment Video
Updated: Apr 12, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinoma
Woo Daniel Park1, Bob T Li2, Richard Maher3
1Department of Medical Oncology , Royal North Shore Hospital, St Leonards , Sydney, NSW , Australia.
Abstract:
A 54-year-old woman with a known history of multifocal hepatocellular carcinoma was treated with selective internal radiation therapy (SIRT) using yttrium-90 ((90)Y) microspheres, despite disease relapses after surgical resection and transarterial chemoembolization. She developed a dramatic clinical, radiological and metabolic response after 9 weeks. This case provides visual illustration of the potential roles of SIRT in the treatment of hepatocellular carcinoma.

